Diiodohydroxyquinoline

Overview

Diiodohydroxyquinoline (Iodoquinol, 5,7-Diiodo-8-hydroxyquinoline, 5,7-Diiodo-8-quinolinol) has an orally active and satisfactory antiparasitic properties. Diiodohydroxyquinoline exhibits mutagenic potential in mice and potent anti- SARS-CoV-2 activity with an EC 50 value of 1.38 μM in VeroE6 cells. Diiodohydroxyquinoline's antimutagen is ascorbic acid. Diiodohydroxyquinoline is promising for research in inflammationin, testinal amebiasis, amebic liver abscess and chronic nonspecific diarrheas.

Application

Products | Products > Disease Areas > Parasitic Infection | Products > Disease Areas > Infection | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Viral Infection | Products > Signaling Pathways > Others | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Infection | Products > Signaling Pathways > Environmental Pollutants | Products > Signaling Pathways > SARS-CoV | Products > Signaling Pathways > Parasite

Product Information

• Catalog No.: HY-B1400
• CAS No.: 83-73-8
• Molecular Formula: C9H5I2NO
• Molecular Weight: 396.95
• Purity: 98.0%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: 2.5 mg/mL (6.30 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source